Global Hormone Replacement Therapy Market, By Type (Estrogen Hormone Replacement, Growth Hormone Replacement, Testosterone Replacement, Thyroid Hormone Replacement, Others), Route of Administration (Oral, Parenteral), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2029.
Hormone Replacement Therapy Market Analysis and Size
The global hormone replacement therapy market is expected to witness significant growth during the forecast period. Ever use of hormone replacement therapy was stated as 43.5% and current use, as 35% of the women. Each one of the women experiences menopause differently, but symptoms such as hot flashes, mood changes, and other symptoms are common and hormone replacement are very helpful in this regard. In addition to this, Many studies showed that people on HRT therapy are most likely to have a low risk of COVID-19 infection and mortality rate.
Data Bridge Market Research analyses a growth rate in the global hormone replacement therapy market in the forecast period 2022-2029. The expected CAGR of global hormone replacement therapy market tend to be around 6.9% in the mentioned forecast period. The market was valued at USD 31.4 billion in 2021, and it would grow upto USD 53.55 billion by 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Market Definition
Hormone replacement therapy is a kind of hormone therapy widely used in treating multiple endocrine diseases. This therapy works either as replacement or replacing the hormones which are deficient and is responsible to cause the disease. The most prominent use of hormone replacement therapy lies in the treatment of menopause’s symptoms in postmenopausal women.
Hormone Replacement Therapy Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (Estrogen Hormone Replacement, Growth Hormone Replacement, Testosterone Replacement, Thyroid Hormone Replacement, Others), Route of Administration (Oral, Parenteral), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
AbbVie Inc. (U.S.), Bausch Health Companies Inc. (Canada), Teva Pharmaceutical Industries Ltd. (Israel), Perrigo Company plc (Ireland), Cipla Inc. (India), Lupin (India), Sun Pharmaceuticals Industries Ltd. (India), Hikma Pharmaceuticals PLC (U.K.), Johnsons & Johnsons Services Inc (U.S.), Boehringer Ingelheim International GmbH (U.S.), Sanofi (France), AstraZeneca (U.K.), GSK Plc. (U.K.), Pfizer Inc. (U.S.), Amneal Pharmaceuticals LLC. (U.K.), Alvogen (U.S.)
|
|
Market Opportunities
|
|
Global Hormone Replacement Therapy Market Dynamics
Drivers
- Increasing Awareness
The rising awareness about hormone deficiency and associated disorders is expected to boost market growth. For instance, a UK-based non-government organization named Child Growth Foundation is dedicated to supporting people living with rare hormone disorders. This organization provides optimum information and immense support to patients, caregivers, & healthcare professionals to improve the life of the patients.
- Increase in Elderly Population
Several hormone levels, for instance, testosterone decrease naturally as age increases beyond 30 years. With the rising global geriatric population of around 2 billion by 2050 compared to 524 million in 2010, the geriatric population is likely to be more prone to this deficiency. Thus, it boosts the market growth.
Opportunities
- Increased Clinical Studies and Government Initiatives
Rising awareness about the drugs and studies that are conducted for development in identifying the harmful compositions for the body that by government and private companies for better knowledge of these drugs is likely to drive the market growth.
- Introduction of Novel Therapies
The growing involvement of major market players in the development of multiple novel therapies is resulting in the launch of new products in the market. For instance, Ascendis Pharma A/S received European Commission's market authorization in January 2022 for its drug SKYTROFA. It is used for the treatment of children and adolescents who are suffering from growth hormone disorders. This product is taken once a week for growth hormone deficiency in the pediatric population.
Restraints/Challenges
- Risk of Complications
There are high risk of complications associated with the hormone replacement therapy. Complications such as sleep apnea, acne or other skin reactions, breast enlargement, increased risk of blood clots and many others are witnessed post the therapy. Thus, it hampers the market growth.
- High Cost
The huge expenditure associated with these therapies surely hamper the market growth.
This global hormone replacement therapy market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global hormone replacement therapy market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Global Hormone Replacement Therapy Market
COVID-19 had a huge impact on the hormone replacement therapy market during the forecast period. Transition of healthcare infrastructure toward managing COVID-19 has led to drug launch cancellations and delays in clinical trials.
Patients with COVID-19 having irregular hormone concentration during hospitalization was found to be associated with the severity of disease and inflammation in men and women. Research showed that COVID-19 increases the need for hormone treatment and will accelerate the market growth. Whereas few other studies have suggested that during COVID-19, the therapy should be discontinued, hence affecting the market growth.
Global Hormone Replacement Therapy Market Scope
The global hormone replacement therapy market is segmented on the basis of type, route of administrtaion, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Estrogen Hormone Replacement
- Growth Hormone Replacement
- Testosterone Replacement
- Thyroid Hormone Replacement
- Others
Route of Administration
- Oral
- Parenteral
End User
- Hospitals
- Homecare
- Specialty Clinics
- Others
Distribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Hormone Replacement Therapy Market Regional Analysis/Insights
The global hormone replacement therapy market is analysed and market size insights and trends are provided by type, route of administration, distribution channel and end-user as referenced above.
The major countries covered in the global hormone replacement therapy market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America has been witnessing a positive growth for global hormone replacement therapy market throughout the forecast period due to the well-established healthcare infrastructure and increasing initiatives the pharmaceutical organizations took to generate novel formulation.
Asia-Pacific dominates the market due to the increase’s cases of cardiovascular diseases and rapidly aging population.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Global Hormone Replacement Therapy Market Share Analysis
The global hormone replacement therapy market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global hormone replacement therapy market.
Key players operating in the global hormone replacement therapy market include:
- AbbVie Inc. (U.S.)
- Bausch Health Companies Inc. (Canada)
- Teva Pharmaceutical Industries Ltd. (Israel)
- Perrigo Company plc (Ireland)
- Cipla Inc. (India)
- Lupin (India)
- Sun Pharmaceuticals Industries Ltd. (India)
- Hikma Pharmaceuticals PLC (U.K.)
- Johnsons & Johnsons Services Inc (U.S.)
- Boehringer Ingelheim International GmbH (U.S.)
- Sanofi (France)
- AstraZeneca (U.K.)
- GSK Plc. (U.K.)
- Pfizer Inc. (U.S.)
- Amneal Pharmaceuticals LLC. (U.K.)
- Alvogen (U.S)
SKU-